Documents

MEB 13: Nomenclature of pharmaceutical products

This document describes the requirements which the marketing authorisation holder has to fulfil when submitting a proposal for a ...

Policy document | 23-03-2020

MEB 6: Labelling of pharmaceutical products

The presentation of the primary and secondary packaging of a medicinal product are determining factors in the recognition of a ...

Policy document | 23-03-2020

MEB Science Day 2020 - Presentation Fiona Sewell

Publication | 04-03-2020

MEB Science Day 2020 - Presentation Coenraad Hendriksen

Publication | 04-03-2020

MEB Science Day 2020 - Presentation Coen Stalpers

Publication | 04-03-2020

MEB Science Day 2020 - Presentation Roos Masereeuw

Publication | 04-03-2020

MEB Science Day 2020 - Presentation Peter van Meer

Publication | 13-02-2020

MEB 44: Direct Healthcare Professional Communications (DHPCs)

This document is based on the Guideline on Good Pharmacovigilance Practices (GVP) Module XV – Safety communication, and is aimed ...

Policy document | 20-01-2020

Product types and fees

The list of product types indicates the various product types handled by the MEB. The choice of the product type determines the ...

Publication | 01-01-2020

Declaration for the package leaflet of parallel imported products

Form | 01-01-2020